SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 153 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,975,419 | +0.3% | 85,442 | +13.8% | 0.00% | 0.0% |
| Q2 2023 | $1,968,676 | +119.5% | 75,083 | +115.5% | 0.00% | 0.0% |
| Q1 2023 | $896,910 | +3.3% | 34,845 | +0.6% | 0.00% | 0.0% |
| Q4 2022 | $868,287 | -8.0% | 34,621 | +1.7% | 0.00% | 0.0% |
| Q3 2022 | $943,781 | +9.4% | 34,036 | -0.8% | 0.00% | 0.0% |
| Q2 2022 | $862,493 | -46.8% | 34,326 | +23.2% | 0.00% | 0.0% |
| Q1 2022 | $1,621,933 | +71.1% | 27,867 | +82.8% | 0.00% | 0.0% |
| Q4 2021 | $948,000 | -2.2% | 15,248 | -0.2% | 0.00% | 0.0% |
| Q3 2021 | $969,000 | -30.0% | 15,276 | -9.1% | 0.00% | 0.0% |
| Q2 2021 | $1,385,000 | +35.8% | 16,808 | +21.2% | 0.00% | 0.0% |
| Q1 2021 | $1,020,000 | -3.9% | 13,867 | -5.2% | 0.00% | 0.0% |
| Q4 2020 | $1,061,000 | +72.2% | 14,635 | +13.3% | 0.00% | 0.0% |
| Q3 2020 | $616,000 | +11.8% | 12,919 | -1.5% | 0.00% | 0.0% |
| Q2 2020 | $551,000 | +175.5% | 13,119 | +77.1% | 0.00% | – |
| Q1 2020 | $200,000 | – | 7,407 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $79,313 | 9.91% |
| Finepoint Capital LP | 614,231 | $15,810,306 | 6.04% |
| M28 Capital Management LP | 197,700 | $5,088,798 | 5.75% |
| Boxer Capital, LLC | 3,421,541 | $88,070 | 4.33% |
| Deep Track Capital, LP | 3,100,000 | $79,794,000 | 3.28% |
| EcoR1 Capital, LLC | 3,460,208 | $89,065,754 | 2.87% |
| Artal Group S.A. | 1,817,349 | $46,779 | 2.78% |
| Orbimed Advisors | 4,498,900 | $115,801,686 | 2.27% |
| Perceptive Advisors | 2,079,352 | $53,522,520 | 1.58% |
| SPHERA FUNDS MANAGEMENT LTD. | 317,625 | $8,175,668 | 1.37% |